Protein-bound sialic acid (PBSA) was measured in serial plasma specimens from 62 healthy subjects, 48 patients with colorectal polyps, and 30 patients with colorectal adenocarcinomas. The mean plasma PBSA concentration in healthy smokers was significantly greater than that in healthy nonsmokers and healthy ex-smokers (P <0.0001). Villoglandular polyps were associated with higher plasma PBSA values than were the most benign hyperplastic polyps (P <0.025). Patients with the most neoplastic villoglandular and villous polyps had significantly greater (P <0. 
(13); the seromucoids in the supernate are precipitated with phosphotungstic acid. We used this latter procedure to assay PBSA.
In this study, we have investigated the potential usefulness of PBSA in plasma as a marker for early stage colorectal cancer in patients with known colorectal polyp histologies and with known histories of polypectomy and smoking. Additionally, we have evaluated the effect of surgery on the plasma concentration of PBSA in cancer patients and in patients with colorectal polyps.
MaterIals and Methods

Patients and Specimens
Plasma specimens were prepared from blood collected by venipuncture from three groups of subjects; tripotassium EDTA was used as the anticoagulant.
The first group consisted of 62 healthy subjects, confirmed to be free of any gastrointestinal disease or other illnesses by medical examination and by review of their medical histories. Thirty-two were men (ages 32-73 years; mean, 55 years) and 30 were women (ages years; mean, 47 years); 35 were nonsmokers, 18 were ex-smokers (had not smoked for at least the last six months), and nine were smokers. Twenty-eight of the healthy control subjects had a second PBSA value determined 2.6-7.9 months (mean, 3.5 months) later.
The second group of subjects comprised 48 patients who had colorectal polyps of defined histology; 26 patients were experiencing their first occurrence and 22 a recurrence of their polyps. Twenty-one of these patients had hyperplastic polyps and 27 had neoplastic polyps (19 tubular adenomatous, six villoglandular, and two villous polyps). These were 35 men (ages 26-84 years; mean, 56 years) and 13 women (ages 37-77 years; mean, 58 years). Blood specimens (n = 53) were collected from the 48 patients at 0.0 to 20.0 (mean 2.6) months before polypectomy. Blood samples were collected from 33 of these patients bothbefore and after polypectomy. The interval between pre-polypectomy blood collection and surgery ranged from 0.0 to 7.1 (mean 0.5) months; the interval between polypectomy and post-surgical blood collection ranged from 0.5 to 4.6 (mean 2. (14, 17) in comparing the means of more than one group to a control group. In the case of the negative control group (the healthy subjects), the null hypothesis was that the mean values for plasma PBSA of other groups were not greater than that of the healthy subjects. In the caseof the positive control group (the cancer patients), the null hypothesis was that the mean values for plasma PBSA of other groups were not less than that of the cancer patients. In all the statistical tests, the level of significance was the most commonly used a = 0.05 (probability of Type I error).
Results and DiscussIon Plasma PBSA in Healthy Subjects ferent (P <0.001) from that for nonsmokers and for ex-smokers. The mean value of plasma PBSA for exsmokers was also significantly different (P <0.010) from the mean for nonsmokers. between the means of the first and second values in the whole group or in the subgroups of the healthy subjects as defined by their smoking histories (P >0.50). Also, there was no significant correlation between plasma concentration of PBSA and age, as assessed by the slope of the linear-regression line, which was not significantly different from zero, and the mean PBSA value for men Patients with villoglandular polyps had significantly greater PBSA values than did those with the most benign hyperplastic polyps (P <0.025). But there was no significant difference in the mean concentrations of plasma PBSA in patients with first occurrence of their polyps and those with recurrent polyps. Furthermore, no relation to polyp recurrence was observed after the patients were grouped on the basis of either polyp histology or smoking history.
Effect of Polypectomy on Plasma PBSA
The effect of polypectomy on plasma concentrations of PBSA was studied in 36 instances involving 33 patients (Table 2) . For all polyp patients as a group, polypectomy did not cause any statistically significant (P >0.25) decrease in plasma PBSA. When the patients were grouped on the basis of polyp histology, smoking history, and polyp recurrence, and these factors were analyzed individually and in combination, polypectomy significantly decreased the plasma concentration of PBSA to the mean value for healthy subjects only for patients with villoglandular (P <0.010) or villous (P <0.050) polyps, strongly suggesting that these neoplastic polyps are the source of increased plasma PBSA in these patients. Figure 3 illustrates the pre-and post-surgical PBSA values for the 30 patients with colorectal adenocarcinomas, grouped according to the stages of their disease. The mean pre-surgical PBSA value for the cancer patients was significantly greater than the mean first PBSA value for the healthy subjects (P 40.001) and than the pre-polypectomy PBSA mean of the polyp patients (P <0.001). Grouped according to smoking histories, cancer patients who were nonsmokers or cxsmokers had mean pre-surgical concentrations of plasma PBSA that were significantly (P <0. (194 mgIL, n = 4), but the differences in mean PBSA between these groups were not statistically significant. Table 3 lists the mean pre-surgical concentrations of plasma PBSA in the cancer patients and the mean first concentrations of plasma PBSA in the healthy subjects.
Plasma PBSA in Cancer Patientsand the Effectof Surgery
The effect of surgery on the mean concentration of PBSA in the cancer patients is also illustrated. In this report we focused on comparisons of mean PBSA values in various groups and on assessing the effect of surgery on the mean PBSA values of polyp and cancer patients. In addition, the effect of surgery may be assessedfor each patient by using a "reference change" for plasma PBSA, as was done in an earlier report (20) for the 10 cancer patients for whom both pre-and post-surgery PBSA values were available.
An extensive search of the literature did not show any study of the plasma concentration of PBSA in patients with colorectal polyps. The number and size of polyps and cancers and the relationship between the extent of smoking and plasma concentration of PBSA were not studied; these will be examined in future studies as these data become available.
